Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05305235 · ClinicalTrials.gov registry record · NA

RCT for Innovating Stress-related eHealth

A NA study, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
75
Enrollment target

NCT05305235 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 75 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05305235, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
75 participants
Enrollment target

Study Summary

The Randomized Control Trial for Innovating Stress-related eHealth (RISE) Study tests the hypotheses that a highly promising digital therapeutic (RISE Guide) targeting anxiety sensitivity (AS) will be acceptable to women sexual assault survivors; reduce survivors' anxiety sensitivity, and, in turn, posttraumatic stress. If successful, RISE Guide could be provided at no cost to all women who present to US emergency departments for emergency care after sexual assault.

Interventions

  • DEVICE RISE Guide
  • DEVICE Relaxation Control

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2021-12-01
Est. Completion 2024-02-24
Phase NA

What the Registry Record Tells You About NCT05305235

The ClinicalTrials.gov registry entry for NCT05305235 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which RISE Guide is the first listed.

NCT05305235 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05305235 about?

NCT05305235 is a clinical study titled "RCT for Innovating Stress-related eHealth". The Randomized Control Trial for Innovating Stress-related eHealth (RISE) Study tests the hypotheses that a highly promising digital therapeutic (RISE Guide) targeting anxiety sensitivity (AS) will be acceptable to women sexual assault survivors; reduce survivors' anxiety sensitivity, and, in turn, ...

What is the current status of trial NCT05305235?

This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2021-12-01. Estimated completion is 2024-02-24.

What interventions are being tested in trial NCT05305235?

The interventions under investigation include: RISE Guide (DEVICE), Relaxation Control (DEVICE).

Who is sponsoring clinical trial NCT05305235?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.